KEY FEATURES
| Full Name | Tissue Inhibitors Of Metalloproteinase 3 |
|---|---|
| Synonym | SFD; TIMP Metallopeptidase Inhibitor 3; Metallopeptidase Inhibitor 3; Sorsby Fundus Dystrophy; Pseudoinflammatory |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.15-10ng/mL |
| Sensitivity | 0.06ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human TIMP3 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human TIMP3. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human TIMP3 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human TIMP3, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human TIMP3. You can calculate the concentration of Human TIMP3 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human TIMP3 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 0.52 | 0.85 | 3.53 | 0.5 | 0.77 | 3.76 |
| Standard deviation | 0.03 | 0.05 | 0.11 | 0.03 | 0.04 | 0.13 |
| CV(%) | 5.03 | 5.89 | 3.13 | 6.37 | 5.32 | 3.42 |
RECOVERY
The recovery of Human TIMP3 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 90-102 | 97 |
| EDTA plasma (n=8) | 88-99 | 94 |
| Cell culture media (n=8) | 83-99 | 90 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human TIMP3 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with TIMP3 ELISA Kits
| MMP2 ELISA Kit | publications with TIMP3 and MMP2 |
| MMP9 ELISA Kit | publications with TIMP3 and MMP9 |
| MMP3 ELISA Kit | publications with TIMP3 and MMP3 |
| ADAM17 ELISA Kit | publications with TIMP3 and ADAM17 |
| MMP13 ELISA Kit | publications with TIMP3 and MMP13 |
| MMP14 ELISA Kit | publications with TIMP3 and MMP14 |
| EFEMP1 ELISA Kit | publications with TIMP3 and EFEMP1 |
Pathways associated with TIMP3 ELISA Kit
| Angiogenesis Pathway | Angiogenesis Pathway |
| Endochondral Ossification Pathway | Endochondral Ossification Pathway |
| Matrix Metalloproteinases Pathway | Matrix Metalloproteinases Pathway |
| Oncostatin M Signaling Pathway | Oncostatin M Signaling Pathway |
| Proteoglycans In Cancer Pathway | Proteoglycans In Cancer Pathway |
Diseases associated with TIMP3 ELISA Kit
| Neoplasms | publications with TIMP3 and Neoplasms |
| Adenocarcinoma | publications with TIMP3 and Adenocarcinoma |
| Necrosis | publications with TIMP3 and Necrosis |
| Inflammation | publications with TIMP3 and Inflammation |
| Breast Neoplasms | publications with TIMP3 and Breast Neoplasms |
| Neoplasm Metastasis | publications with TIMP3 and Neoplasm Metastasis |
| Carcinoma, Squamous Cell | publications with TIMP3 and Carcinoma, Squamous Cell |
| Liver Diseases | publications with TIMP3 and Liver Diseases |
| Neoplasms, Experimental | publications with TIMP3 and Neoplasms, Experimental |
| Liver Neoplasms | publications with TIMP3 and Liver Neoplasms |
Organs/Tissues associated with TIMP3 ELISA Kit
| Eye | publications with TIMP3 and Eye |
| Vascular | publications with TIMP3 and Vascular |
| Blood | publications with TIMP3 and Blood |
| Liver | publications with TIMP3 and Liver |
| Lung | publications with TIMP3 and Lung |
| Muscle | publications with TIMP3 and Muscle |
| Embryonic Tissue | publications with TIMP3 and Embryonic Tissue |
| Bone | publications with TIMP3 and Bone |
| Kidney | publications with TIMP3 and Kidney |
| Heart | publications with TIMP3 and Heart |